Relay Therapeutics Inc | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (15)

Latest Posts

About This Stock More About This Stock
5 Of 7 AI Categories Rose, Slightly, Over Past Week
Article By: Lorimer Wilson
Saturday, May 11, 2024 7:00 AM EDT
The 7 AI categories we track went up marginally (1.0%, on average) the second week of May, after having gone down 0.4% the previous week.
In this article: TSM, MKSI, MU, SHOP, ABCL, QLYS, RLAY, QBTS, RGTI
Read
The 7 AI Categories Declined, On Average, The First Week Of May
Article By: Lorimer Wilson
Sunday, May 5, 2024 3:05 PM EDT
We track 7 AI categories; here we highlight those stocks in each category that went up or down by 5% or more during the week.
In this article: ATEYY, BIDU, FTNT, SDGR, CYBR, RLAY, RGTI
Read
Clinical-Stage BioTech Drug Stocks Portfolio Jumped 7% In First Week Of May
Article By: Lorimer Wilson
Sunday, May 5, 2024 12:02 AM EDT
We look at the performance of 10 clinical-stage AI-powered and psychedelic compound-based small cap drug discovery companies during the first week of May and YTD.
In this article: EXAI, ATAI, SDGR, MNMD, CMPS, ABCL, RLAY, GHRS, ABSI, RXRX
Read
AI Surge Ending: Only One Category Was Up This Week
Article By: Lorimer Wilson
Saturday, April 6, 2024 7:00 PM EDT
Six of the 7 categories we cover dropped this week, compared with 3 in March. The data clearly indicates that the surge in this sector is stalling or perhaps is even over.
In this article: AIQ, AMD, ATEYY, FTNT, EQIX, MU, SNPS, PANW, ANET, PSTG, ZS, DELL, RLAY, RXRX, QBTS, RGTI
Read
AI-Powered Drug Discovery Stocks Index Up 9% In February; Remains Down 8% YTD
Article By: Lorimer Wilson
Monday, March 4, 2024 12:41 AM EDT
Grand View Research says the global "AI in drug discovery" market should expand at a CAGR of 30% between now, and 2030 which Morgan Stanley believes will lead to 50 novel therapies over the next decade, with annual sales in excess of $50 billion.
In this article: EXAI, SDGR, ABCL, BTAI, RLAY, LTRN, ABSI, RXRX
Read

Latest Tweets for $RLAY

No tweets yet!

PARTNER HEADLINES